AN2 Therapeutics Inc (ANTX) — Defensive Interval Ratio
AN2 Therapeutics Inc (ANTX) has a Defensive Interval Ratio of 1631 days as of December 2025. Defensive assets of $38.96 Million (cash $-, short-term investments $38.06 Million, receivables $900.00K) cover 1631 days of daily cash needs of $23.89K/day. See ANTX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
AN2 Therapeutics Inc Defensive Interval Ratio (2020–2025)
This chart shows how AN2 Therapeutics Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 1631 days, meaning defensive assets of $38.96 Million can fund 1631 days of operations without new revenue. See ANTX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for AN2 Therapeutics Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for AN2 Therapeutics Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AN2 Therapeutics Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1631 days | $38.96 Million | $23.89K/day | $- | $38.06 Million | ▼ -600 days |
| 2024 | 2231 days | $62.57 Million | $28.05K/day | $- | $62.27 Million | ▼ -188 days |
| 2023 | 2418 days | $93.05 Million | $38.47K/day | $- | $91.65 Million | ▼ -1078 days |
| 2022 | 3497 days | $68.84 Million | $19.69K/day | $- | $68.84 Million | ▼ -1498 days |
| 2021 | 4995 days | $46.46 Million | $9.30K/day | $- | $46.46 Million | ▲ +4995 days |
| 2020 | 0 days | $0.00 | $4.00K/day | $- | $0.00 | — |